Is WST Stock Undervalued At $200? [Forbes]
West Pharmaceutical Services, Inc. (WST)
Last west pharmaceutical services, inc. earnings: 4/23 06:00 am
Check Earnings Report
US:NYSE Investor Relations:
investor.westpharma.com
Company Research
Source: Forbes
SOPA Images/LightRocket via Getty Images West Pharmaceutical Services , a global provider of solutions for drugs, biologics, gene therapies, and consumer healthcare products, recently announced its Q4 results, surpassing analysts' expectations for both revenue and earnings. The company reported sales of $749 million and adjusted earnings per share of $1.82, compared to $740 million and $1.73, respectively. However, its future guidance fell short of market expectations, leading to a decline in its stock price after the announcement. WST stock has dropped 43% since the start of 2024, significantly underperforming the S&P 500 index, which has gained 28% over the same period. Weakness in its generics and biologics segments has weighed on its share price recently. If you're looking for a less volatile investment option, consider the High-Quality Portfolio , which has outperformed the S&P 500, delivering over 91% returns since its inception. West Pharmaceutical Services' revenue for
Show less
Read more
Impact Snapshot
Event Time:
WST
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
WST alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
WST alerts
High impacting West Pharmaceutical Services, Inc. news events
Weekly update
A roundup of the hottest topics
WST
News
- West to Participate in Upcoming Investor ConferencePR Newswire
- West Declares Quarterly DividendPR Newswire
- West Pharmaceutical Services (NYSE:WST) was downgraded by analysts at <a style="font-weight:bold" href="https://www.wallstreetzen.com/newsletters/zen-ratings?ticker=WST&utm_campaign=getratings&utm_medium=online&utm_source=MarketBeat">WalMarketBeat
- The Bull Case For West Pharmaceutical Services (WST) Could Change Following Margin Squeeze And Slower Revenue Growth [Yahoo! Finance]Yahoo! Finance
- West Pharmaceutical Services (WST) Rebounded in Q3 [Yahoo! Finance]Yahoo! Finance
WST
Earnings
- 10/23/25 - Beat
WST
Sec Filings
- 12/10/25 - Form 4
- 12/10/25 - Form 3
- 10/31/25 - Form SCHEDULE
- WST's page on the SEC website